Anifrolumab manufacturers
- Anifrolumab
-
- $197.00
-
2026-08-14
- CAS:1326232-46-5
- Purity: 95.00%
- Supply Ability: 10g
|
| | Anifrolumab Basic information |
| Product Name: | Anifrolumab | | Synonyms: | Anifrolumab;Research Grade Anifrolumab(DHD23001);Anifrolumab (anti-IFNAR1);MDX-1333|||MEDI-546;Anti-Human IFNAR1 Monoclonal Antibody(Anifrolumab);Research Grade Anifrolumab | | CAS: | 1326232-46-5 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Anifrolumab Structure]() |
| | Anifrolumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Anifrolumab Usage And Synthesis |
| Uses | Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research[1][2]. | | References | [1] Furie R, et al. Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 Feb;69(2):376-386. DOI:10.1002/art.39962
[2] Riggs JM, et al. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. Lupus Sci Med. 2018 Apr 5;5(1):e000261. DOI:10.1136/lupus-2018-000261 |
| | Anifrolumab Preparation Products And Raw materials |
|